POLYPEPTIDE N news, videos and press releases
For more news please use our advanced search feature.
POLYPEPTIDE N - More news...
POLYPEPTIDE N - More news...
- PolyPeptide announces results of the annual General Meeting 2025
- PolyPeptide publishes invitation to the annual General Meeting 2025
- PolyPeptide with substantial improvements in profitability and cash flow, positioned for strong growth
- Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs
- Doubling of production capacity at the manufacturing site in Malmö
- Large-scale SPPS capacity in Braine-l’Alleud starts production
- Solid progress in H1 2024 – Upgrade of 2024 full-year guidance – Mid-term target to double 2023 revenue by 2028
- PolyPeptide appoints Chief Commercial Officer
- PolyPeptide announces results of the annual General Meeting 2024
- PolyPeptide publishes invitation to the annual General Meeting 2024
- PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow
- PolyPeptide signs scientific collaboration agreement
- PolyPeptide secures revolving credit facility
- Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO
- PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023
- PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs
- PolyPeptide announces results of the annual General Meeting 2023
- PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO
- PolyPeptide publishes invitation to the annual General Meeting 2023
- Sirnaomics to Present Latest Developments in Polypeptide Nanoparticle Platform at the 4th Annual RNAi-Based Therapeutics Summit
- PolyPeptide reports weaker performance in 2022 – expects growth to recover in the second half of 2023
- PolyPeptide: CEO of PolyPeptide resigns
- PolyPeptide signs significant commercial agreement
- PolyPeptide provides market update
- PolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022
- PolyPeptide Group provides market update
- PolyPeptide Group: Monika Casanova joining PolyPeptide as CHRO and member of the PMC
- PolyPeptide Group announces results of the annual General Meeting 2022
- PolyPeptide publishes invitation to the annual General Meeting 2022
- PolyPeptide achieves strong profitable growth in 2021
